Evidence map›Paper›PMID 30911686›Full record

ArticleCommunications biology2019

Activated cofilin exacerbates tau pathology by impairing tau-mediated microtubule dynamics.

Jung-A A Woo, Tian Liu, Cenxiao C Fang, Sara Cazzaro, Teresa Kee, Patrick LePochat, Ksenia Yrigoin, Courtney Penn, Xingyu Zhao, Xinming Wang and 2 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Communications biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. A New Molecular Mechanism for the Late-Onset Alzheimer's Disease Risk Gene CD2AP.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Jung-A A Woo1USF Health Byrd Alzheimer's Institute, University of South Florida, Morsani College of Medicine, Tampa, FL 33613 USA.
Tian Liu1USF Health Byrd Alzheimer's Institute, University of South Florida, Morsani College of Medicine, Tampa, FL 33613 USA.
Cenxiao C Fang1USF Health Byrd Alzheimer's Institute, University of South Florida, Morsani College of Medicine, Tampa, FL 33613 USA.
Sara Cazzaro1USF Health Byrd Alzheimer's Institute, University of South Florida, Morsani College of Medicine, Tampa, FL 33613 USA.
Teresa Kee1USF Health Byrd Alzheimer's Institute, University of South Florida, Morsani College of Medicine, Tampa, FL 33613 USA.
Patrick LePochat1USF Health Byrd Alzheimer's Institute, University of South Florida, Morsani College of Medicine, Tampa, FL 33613 USA.
Ksenia Yrigoin1USF Health Byrd Alzheimer's Institute, University of South Florida, Morsani College of Medicine, Tampa, FL 33613 USA.
Courtney Penn1USF Health Byrd Alzheimer's Institute, University of South Florida, Morsani College of Medicine, Tampa, FL 33613 USA.
Xingyu Zhao1USF Health Byrd Alzheimer's Institute, University of South Florida, Morsani College of Medicine, Tampa, FL 33613 USA.
Xinming Wang1USF Health Byrd Alzheimer's Institute, University of South Florida, Morsani College of Medicine, Tampa, FL 33613 USA.
Stephen B Liggett1USF Health Byrd Alzheimer's Institute, University of South Florida, Morsani College of Medicine, Tampa, FL 33613 USA.
David E Kang1USF Health Byrd Alzheimer's Institute, University of South Florida, Morsani College of Medicine, Tampa, FL 33613 USA.
University of South Florida · USUSF Health Byrd Alzheimer's Institute · US

Funding

Role of the Slingshot-1 pathway in APP and Tau pathogenesisRF1AG053060 · NIA · UNIVERSITY OF SOUTH FLORIDA · PI KANG, DAVID E · 2017 to 2017
$1.9M
Molecular Intermediates and Regulation of the Abeta-Tau Pathogenic CascadeI01BX002478 · VA · JAMES A. HALEY VA MEDICAL CENTER · PI KANG, DAVID E · 2015 to 2019
–
BLRD VA I01 BX002478NIA NIH HHS RF1 AG053060
6 · The paper itself

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the most common form of dementia. While the accumulation of Aβ is pivotal to the etiology of AD, both the microtubule-associated protein tau (MAPT) and the F-actin severing protein cofilin are necessary for the deleterious effects of Aβ. However, the molecular link between tau and cofilin remains unclear. In this study, we found that cofilin competes with tau for direct microtubule binding in vitro, in cells, and in vivo, which inhibits tau-induced microtubule assembly. Genetic reduction of

Indexed as

Transcriptional ActivationActin Depolymerizing FactorsAnimalsCaenorhabditis elegansDisease Models, AnimalMiceMice, KnockoutMicrotubulesNeuronsProtein BindingTauopathiestau ProteinsTubulinActin Depolymerizing Factorstau ProteinsTubulin

Identifiers

PMID30911686
PMCPMC6430779
OpenAlexW2924084058

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.